INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 137 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $501 | -99.9% | 14,355 | +37.9% | 0.06% | -19.5% |
| Q3 2022 | $582,000 | +18.3% | 10,407 | -69.0% | 0.08% | +35.1% |
| Q4 2019 | $492,000 | -1.6% | 33,533 | +9.7% | 0.06% | +1.8% |
| Q2 2019 | $500,000 | +182.5% | 30,555 | +194.5% | 0.06% | +211.1% |
| Q1 2019 | $177,000 | -83.8% | 10,374 | -80.0% | 0.02% | -69.0% |
| Q1 2018 | $1,095,000 | -39.7% | 51,900 | -29.0% | 0.06% | -53.2% |
| Q3 2017 | $1,817,000 | +100.3% | 73,100 | +28.9% | 0.12% | +110.2% |
| Q2 2017 | $907,000 | – | 56,700 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |